Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

The Moscow Exchange announced the date of delisting of Yandex N. V. shares

5/14/24 YDEX

The Moscow Exchange announced the date of delisting of Yandex N. V. shares

5/14/24 YNDX

St. Petersburg Stock Exchange determined the main directions of development of the platform

5/14/24 SPBE

Aeroflot increases passenger traffic in April 2024

5/14/24 AFLT

Svetofor Group plans to place 10% of its shares on SPVB during the IPO

5/14/24 SVET

Sberbank reports on RAS for April

5/14/24 SBER

Abrau-Durso increased sales by 30% in the first quarter of 2023%

5/14/24 ABRD

Board of Directors of Stavropolenergosbyt recommended that dividends be paid for 2023

5/14/24 STSB

Yandex N.V. has applied to delist its shares from the Moscow Exchange

5/13/24 YDEX

The Board of Directors of TRK announced dividends based on the results of 2023

5/13/24 TORS